酵母纺锤体极体复制缺陷与染色体不稳定性的发生

纺锤体极体作为酵母细胞的微管组织中心,在功能上等同于高等真核细胞的中心体,它在细胞周期中的准确复制是两极纺锤体组装和染色体正确分离的前提。纺锤体极体复制缺陷会导致异倍体和多倍体的形成,造成染色体不稳定性的发生。以酿酒酵母细胞为模型,研究纺锤体极体复制过程相关蛋白质的突变,有助于揭示酵母细胞中染色体不稳定性发生的分子机制,并为动物细胞中心体复制的研究提供良好的借鉴。     

中心体异常扩增和染色体不稳定性

中心体作为主要微管组织中心在细胞周期事件中起着重要的作用。异常中心体可产生纺锤体异常,使染色体错误分离,引起染色体不稳定性和非整倍体的形成。中心体异常同染色体不稳定性一样是肿瘤细胞的一个普遍特征,并且可出现在肿瘤发生的早期阶段。中心体异常在肿瘤的发生发展演化过程中可能具有重要作用。现综述中心体的结构、功能、复制和调控,阐述肿瘤中中心体异常的表现和导致中心体扩增的可能机制及中心体扩增与染色体不稳定之间的相关性。     

线粒体微卫星DNA不稳定性与肿瘤关系的研究进展

线粒体DNA直接控制细胞氧化磷酸化过程,其基因组序列发生突变尤其是微卫星DNA 不稳定性会严重降低线粒体产生能量的功能,诱发细胞程序性死亡和癌细胞形成。目前,有关人类线粒体微卫星DNA不稳定性与肿瘤关系的研究越来越受到关注。仅就微卫星DNA的特点和不稳定性形成的机理以及与肿瘤关系的研究进展作以概述。     

骨盆骨折的护理体会

骨盆骨折大多是一种严重多发伤,常由车祸、塌方、爆炸伤所致,多伴有各种并发伤及失血性休克。为此,积极地配合抢救,准确地判断及观察病情,精心护理,是病人恢复病情的重要保证。现将我科2000～2004年收治的20例骨盆骨折并失血性休克病人的护理体会报告如下。     

两种低分子肝素治疗不稳定性心绞痛86例观察

不稳定心绞痛（UA）病理基础为不稳定粥样斑块,可随时进展为心肌梗死,正确的诊断和治疗将在很大程度上改善预后。本文对比两种低分子肝素（LMWH）对UA的疗效及安全性。     

癌组织中的遗传不稳定性的RAPD分析（简报）

In five kinds of tumors, total 128 specimens were analyzed by RAPD (random amplified polymorphic DNA) PCR with nine 10-base arbitrary primers for detecting instabilities of DNA and chromosome and screening new molecular markers coupled to putative or unknown oncogenes and/or tumor suppressor genes. Bands representing instabilities have been recovered and purified from agarose and cloned into pCAPs vector, and further labeled by DIG as probes for analysis of Southern blot, Northern blot and Sequencing. Results revealed that sample 5 and 3 of the gastric cancers showed the highest genomic changes and the average detectability in five sorts of cancers was up to at least 40% (42.2%-49.4%), and that there were significant differences in the ability of each primer to detect genomic instability, which ranged from 27% to 68%. Despite the highest detectability of genetic instability (68%) in tumor tissues, primer 2 could produce stable profiles of DNA bands in normal tissue genome with good reproducibility. On the contrary, primer 8 was of the lowest one (27%). Band B of single copy found to be allelic losses in gastric and colon cancers according to RFLP analysis was of a novel sequence and registered by Gen-Bank (Accession Number AF151005). Therefore the genetic instabilities often concentrated on some special locuses of chromosome e.g. repetitive sequences etc. and coupled to carcinogenesis. It was impossible or difficult to get great achievements for cancer treatments with the procedure of gene therapy only to one oncogene or one tumor suppressor gene because the extensive DNA variations occurred during the progression of tumor. RAPD assay connected with other techniques was a good tool for the detection of genomic instabilities and direct screening of some new molecular markers related to tumor suppressor genes or oncogenes.     

中国人结肠癌nm23H1基因遗传不稳定性的研究

Techniques such as DNA extraction from paraffin-embedded tissues, polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), ordinary silver stain, Envision immunohistochemistry and Leica-Qwin computer imaging techniques were used to study microsatellite instability (MSI) and loss of heterozygosity (LOH) of locus D17S396 at the 17th chromosome of Chinese patients and their influence on the expression of gene nm23H1, and to clarify the relationship between the genetic instability of gene nm23H1 and the development of colon cancer, which may provide experimental basis for clinical treatment. In our experiments, the frequency of MSI, LOH and nm23H1 protein reacted positive of 30 cases of colon cancer were 26.67%, 20.00% and 53.33% respectively. In tumor node metastasis (TNM) staging, the positive frequency of MSI (43.75%) and nm23H1 protein (81.25%) in stage I + II were more than those (MSI 7.14%, p < 0.05 and nm23H1 21.43%, p < 0.01) in stage III + IV, while the frequency of LOH (35.71%), which had a rising trend along with the Duke's staging increasing, was higher than that of LOH (6.25%, p < 0.05) in stage I + II. The positive frequency of nm23H1 protein in the group of tubular adenocarcinoma (60.00%) was distinctively higher than that in the group of mucoid adenocarcinoma (20.00%, p < 0.01), showing a rising trend along with the increase of the differentiation degree of tubular adenocarcinoma. Furthermore, the positive frequency of nm23H1 protein in MSI positive group was also higher than MSI negative group (p < 0.05). And there was no difference in nm23H1 protein expression analyzed by computer imaging techniques. The results of experiments indicated that both MSI and LOH controlled the development of sporadic colon cancer independently in different paths. LOH occurred mostly in the late period of sporadic colon cancer and endowed with it a high aggressive and poor prognosis. In contrast, MSI was an early period molecule marker of sporadic colon cancer. Increasing the amount of nm23H1 protein expression could effectively restrain colon cancer metastasis and improved prognosis of sporadic colon cancer patients.     

癌组织中的遗传不稳定性的RAPD分析(简报)

肿瘤仍然是导致人类死亡的重要原因,由于缺乏深刻了解癌症的发生机制,尽管在过去25年中肿瘤的诊断和治疗都取得很大的进展,但肿瘤病人的存活率并没有显著的提高。目前有很多癌基因和抑癌基因如P16、P53、P73、ras、DCC和RB等     

蝮蛇抗栓酶对不稳定性心绞痛患者血中部分凝血及纤溶指标的影响

测定３８例不稳定性心绞痛（ＵＡＰ）患者血中纤维蛋白原（Ｆｇ）含量、组织型纤溶酶原激活物（ｔ－ＰＡ）活性、血管性假血友病因子（ｖＷＦ）活性和血小板聚集率水平（ＰＡｇＴ）并与２１名正常人对比。患者中１８例用蝮蛇抗栓酶治疗,２０例行常规治疗。结果显示：ＵＡＰ患者血中ＰＡＩ－１、ｖＷＦ以及ＰＡｇＴ水平明显增高,ｔ－ＰＡ水平明显降低;蝮蛇抗栓酶组治疗后血中Ｆｇ、ＰＡＩ－１、ＰＡｇＴ水平均明显下降,使ｔ－ＰＡ水平明显升高;常规治疗组治疗前后各项指标无明显变化。认为蝮蛇抗栓酶对ＵＡＰ有可靠疗效     

中国人胃癌染色体17q21区域基因遗传不稳定性研究

To investigate microsatellite instability (MSI) and loss of heterozygosity (LOH) of locus D17S396, D17S579 and D17S855, and their effect on the expression of nm23H1 and BRCA1 of gastric cancer, which would provide experimental basis for clinical treatment and prognosis analysis of gastric cancer. DNA was extracted from paraffin-embedded materials. Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was used to analyze MSI and LOH. Expression of nm23H, and BRCA1 was detected by Envision immuno-histochemistry and Leica-Qwin computer imaging techniques. In the forty cases of gastric cancer, the frequency of MSI, LOH and nm23H1 protein were 20.00%, 17.50% and 55.00% respectively at locus D17S396, while at locus D17S579, the frequency of MSI, LOH and BRCA1 protein were 22.50%, 15.00% and 37.50% respectively; at locus D17S855, the frequency of MSI, LOH and BRCA1 of thirty-seven cases were 18.92%, 18.92%, 37.84% respectively. In tumor node metastasis (TNM) staging, at locus D17S396, D17S579 and D17S855, MSI in stages I + II appeared more frequently than that in stages III + IV, while LOH appeared the contrary tendency. In the group of metastasis of gastric cancer, MSI had a less frequency (5.00%) than that with no metastasis (35.00%, P < 0.05) at locus D17S396, but LOH appeared more frequently (30.00%) than that with no metastasis (5.00%, P < 0.05). At locus D17S579, MSI had an increasing tendency with the degree of tumor differentiation (50.00% in high differentiation cases, 20.00% in middle differentiation cases, and 0% in low differentiation cases, P < 0.05). The frequency of nm23H1 and BRCA1 protein in stages TNM I + II was higher than that in stages TNM III + IV; and that in higher differentiation cases was higher than in poor differentiation cases. The frequency of nm23H1 protein in the group of metastasis (30.00%) was less than that with no metastasis significantly (80.00%, P<0.01). The frequency of nm23H1 protein in the group positive to MSI (87.50%) was higher than that in the group negative to MSI (46.88%, P < 0.05). However, nm23H1 protein in group positive to LOH (14.29%) was lower than that in the group negative to LOH (63.64%, P < 0.05). The frequency of BRCA1 protein in the group positive to MSI (66.67%) was more than that in the group negative to MSI (29.03%, P < 0.05). The results of experiments indicate that MSI and LOH may separately control the development of sporadic colon cancer with different pathways. MSI may be an early period molecule marker for sporadic colon cancer, enhanced expression of nm23H1 protein can effectively inhibit colon cancer metastasis and improve prognosis of sporadic colon cancer patients. By comparison, LOH mostly arises in the late period of sporadic colon cancer and endows a high aggressive and poor prognostic phenotype. nm23H1 protein could effectively restrain gastric cancer metastasis and development; and BRCA1 protein could restain tumor from becoming lower differentiation.